Literature DB >> 30138859

The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.

Shani Dahan1, Nicola Luigi Bragazzi2, Ayala Yogev3, Mayan Bar-Gad2, Vivian Barak4, Howard Amital5, Daniela Amital3.   

Abstract

Several observations indicate that cytokine concentrations might also relate to the severity of the psychosis. In this study we assessed whether inflammatory and anti-inflammatory cytokine concentrations are associated with the degree of the psychotic manifestations. A group of 41 patients with schizophrenia suffering from an acute psychosis leading to hospitalization in a psychiatric ward were assessed for the intensity of their psychotic manifestations by the PANSS score. Serum IL-2R, IL-6, IL-8, IL-10 were analyzed by commercial ELISA kits. These patients were compared to controls without schizophrenia. At the univariate analysis, statistically significant elevated levels of the cytokines IL-6, IL-2R and IL-8 were detected in the sera of the patients with schizophrenia compared to controls. At the multivariate analysis, statistically significance held only for IL-2R concentration. Furthermore, positive correlation was found between symptom severity as measured by the PANSS and IL-6 levels as well as IL-2R levels. In Conclusion, our data indicate that elevated serum concentrations of IL-6, IL-8 and IL-2R are associated with severe clinical symptoms measured by the total, general, negative and positive scores of the PANSS scale.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokines; IL-10; IL-6; Inflammation; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 30138859     DOI: 10.1016/j.psychres.2018.07.041

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

Review 1.  Neuroinflammation and Schizophrenia.

Authors:  Peter F Buckley
Journal:  Curr Psychiatry Rep       Date:  2019-07-03       Impact factor: 5.285

2.  Changes in inflammation are related to depression and amount of aerobic exercise in first episode schizophrenia.

Authors:  Joseph Ventura; Sarah McEwen; Kenneth L Subotnik; Gerhard S Hellemann; Manali Ghadiali; Amir Rahimdel; Min Jee Seo; Michael R Irwin; Keith H Nuechterlein
Journal:  Early Interv Psychiatry       Date:  2020-02-13       Impact factor: 2.732

3.  Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.

Authors:  John Abel Engh; Thor Ueland; Ingrid Agartz; Dimitrios Andreou; Pål Aukrust; Birgitte Boye; Erlend Bøen; Ole Kristian Drange; Torbjørn Elvsåshagen; Sigrun Hope; Margrethe Collier Høegh; Inge Joa; Erik Johnsen; Rune Andreas Kroken; Trine Vik Lagerberg; Tove Lekva; Ulrik Fredrik Malt; Ingrid Melle; Gunnar Morken; Terje Nærland; Vidar Martin Steen; Kirsten Wedervang-Resell; Melissa Auten Weibell; Lars Tjelta Westlye; Srdjan Djurovic; Nils Eiel Steen; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

Review 4.  Immunoneuropsychiatry - novel perspectives on brain disorders.

Authors:  Marion Leboyer; Frauke Zipp; Katrin Pape; Ryad Tamouza
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

5.  The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia.

Authors:  Xiaoyan He; Qingyan Ma; Yajuan Fan; Binbin Zhao; Wei Wang; Feng Zhu; Xiancang Ma; Lina Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

Review 6.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

7.  Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients.

Authors:  Paolo Enrico; Giuseppe Delvecchio; Nunzio Turtulici; Alessandro Pigoni; Filippo Maria Villa; Cinzia Perlini; Maria Gloria Rossetti; Marcella Bellani; Antonio Lasalvia; Chiara Bonetto; Paolo Scocco; Armando D'Agostino; Stefano Torresani; Massimiliano Imbesi; Francesca Bellini; Angela Veronese; Luisella Bocchio-Chiavetto; Massimo Gennarelli; Matteo Balestrieri; Gualtiero I Colombo; Annamaria Finardi; Mirella Ruggeri; Roberto Furlan; Paolo Brambilla
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

Review 8.  Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.

Authors:  Fanglin Guan; Tong Ni; Weili Zhu; L Keoki Williams; Long-Biao Cui; Ming Li; Justin Tubbs; Pak-Chung Sham; Hongsheng Gui
Journal:  Mol Psychiatry       Date:  2021-06-30       Impact factor: 15.992

9.  Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.

Authors:  Lyliana G Nasib; Iris E Sommer; Inge Winter-van Rossum; Jacqueline de Vries; Shiral S Gangadin; Priscilla P Oomen; Gurmeet Judge; Renske E Blom; Jurjen J Luykx; Nico J M van Beveren; Natalie D Veen; Rune A Kroken; Erik L Johnsen
Journal:  Trials       Date:  2020-06-08       Impact factor: 2.279

10.  Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: A cross-sectional study.

Authors:  Jeanette Brun Larsen; Astrid Kamilla Stunes; Arne Vaaler; Solveig Klæbo Reitan
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.